Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 29 Neoplasms 10 Brain Neoplasms 6 Neoplasm Metastasis 3 Thyroid Neoplasms 2 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Histiocytosis, Langerhans-Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adenocarcinoma, Follicular 1

Interventions

Cisplatin 32 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12 Paclitaxel 11 Bevacizumab 11 pembrolizumab 9 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiotherapy, Intensity-Modulated 8 Radiation 8 Papillomavirus Vaccines 8 atezolizumab 6 Gemcitabine 6 Fluorodeoxyglucose F18 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Taxes 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Carboplatin 5 Vaccines, Synthetic 4 Nivolumab 4 Immunoglobulin G 4 Disulfides 4 Colposcopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡